ClearStar,Inc. ClearStar agreement with IntelliCentrics (6788A)
28 März 2017 - 8:01AM
UK Regulatory
TIDMCLST TIDMCLSU
RNS Number : 6788A
ClearStar,Inc.
28 March 2017
ClearStar's Titer and Drug Screening Solution to be Integrated
into IntelliCentrics' SEC(3) URE Program for Hospitals and
Healthcare Organisations
ClearStar's automated order placement, registration, automatic
transmission, to eliminate the traditional paper-intensive forms
and inefficient way of collating data for titer and drug screening
tests
ClearStar (AIM: CLSU and CLST), the technology and service
provider to the background check industry, is pleased to announce
that it has entered into a partnership with IntelliCentrics, the
healthcare industry leader with over 10,000 distinct installations
of vendor credentialing across the USA, Canada, and the United
Kingdom.
Under the terms of the partnership, ClearStar's automated titer
and drug screening solution will be integrated into
IntelliCentrics' SEC(3)URE Program for Hospitals and Healthcare
Organisations. The SEC(3)URE healthcare experience is designed to
allow hospitals to control access by healthcare industry
representatives (HIR), by ensuring only those that comply with the
hospital's specific policies gain access to patient sensitive or
restricted areas.
Individual hospitals decide entry requirements, which can
include relevant immunisations, professional accreditations and
compliance with hospital policies. A titer test measures the
existence and levels of antibodies in the blood i.e. the ability to
provoke a response from the immune system to disease. This response
can come from natural exposure or from vaccination. Rather than
hospital staff having to conduct the checks, HIRs pre-register via
the SEC(3)URE system, which confirms their compliance status when
they arrive on site.
With this partnership, IntelliCentrics has the tools for its
members to streamline the titer and drug testing ordering and
results, saving time and money. With automated order placement,
registration, automatic transmission, it will eliminate the
traditional paper-intensive titer and drug test forms, double
data-entry, and multiple logins to the test ordering websites.
"Members of the IntelliCentrics community rely on us to deliver
and provide the most efficient service and technology to do their
jobs at peak levels while concurrently safeguarding a SEC(3) URE
healthcare experience for everyone. Our affiliation with ClearStar
advances our capability to protect our entire community," comments
Mike Sheehan, Global CEO of IntelliCentrics. Sheehan continues "The
partnership between IntelliCentrics and ClearStar is at the core of
our belief that we all play a role in a safe and SEC(3) URE
healthcare experience."
"We are very proud to be working with IntelliCentrics with whom
we share a common goal of assuring safety for the healthcare
providers and patients through this new best-of-breed solution,"
stated Robert Vale, CEO of ClearStar. "By integrating our mobile,
paperless chain of custody technology with IntelliCentrics'
industry-leading service technology infrastructure, we will enable
healthcare personnel to be screened and approved for work more
quickly thereby meeting the aggressive time demands on the
healthcare industry."
Enquiries
ClearStar, Inc.
Robert J. Vale, Chief Executive
Officer
David Pattillo, Chief Financial
Officer +1 770 416 1900
finnCap Ltd.
Jonny Franklin-Adams, Simon
Hicks - Corporate Finance
Christian Hobart, Abigail
Wayne - Corporate Broking +44 20 7220 0500
Luther Pendragon Ltd.
Harry Chathli, Claire Norbury +44 20 7618 9100
Notes to Editors
About ClearStar
ClearStar, Inc. is a leading and trusted background check
technology, strategic services, and decision-making information
provider to employers and background screening companies.
A seven-time Inc. 5000 honouree and founding member of the
National Association of Professional Background Screeners,
ClearStar has provided innovative technology solutions to
businesses in the human capital management industry from its
corporate offices in Alpharetta, Georgia since 1995. For more
information about ClearStar, please visit: www.clearstar.net.
About IntelliCentrics
IntelliCentrics, the security experts, is in the business of
savings lives by creating a safe and SEC(3)URE healthcare
experience. IntelliCentrics is uniquely qualified to help hospitals
and healthcare organizations to provide high-quality patient care.
By prioritizing security, IntelliCentrics facilities meet or exceed
compliance best practices by letting everyone in safely. More
healthcare facilities across seven countries adopt IntelliCentrics
standards than all competitors combined. Now, every person entering
a facility can contribute to preserving patient care, from
physicians to patient visitors, vendors, volunteers, and staff. To
learn more about IntelliCentrics, the leading provider of managed
services to maintain compliance programs to create a safe and
SEC(3)URE healthcare experience, please phone (817) SEC(3)URE or
visit www.IntelliCentrics.com.
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRLLFEAVEIDFID
(END) Dow Jones Newswires
March 28, 2017 02:01 ET (06:01 GMT)
Clrstar (DI/S) (LSE:CLST)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Clrstar (DI/S) (LSE:CLST)
Historical Stock Chart
Von Jan 2024 bis Jan 2025